(Q37634491)

21 August 2017

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk (English)

1 reference

21 August 2017

1 reference

1 reference

George A Makar

1

1 reference

21 August 2017

John H Holmes

series ordinal

2

1 reference

21 August 2017

Yu-Xiao Yang

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

15 January 2014

1 reference

Journal of the National Cancer Institute

21 August 2017

1 reference

21 August 2017

106

1 reference

21 August 2017

2

1 reference

21 August 2017

djt374

1 reference

21 August 2017

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Cardiovascular medication use and risk for colorectal cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Chronic proton pump inhibitor therapy and the risk of colorectal cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Induction of angiogenesis during the transition from hyperplasia to neoplasia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

ANG II stimulates PKC-dependent ERK activation, DNA synthesis, and cell division in intestinal epithelial cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Cancer risk in users of calcium channel blockers.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Biased Selection of Controls for Case-Control Analyses of Cohort Studies

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

The impact of confounder selection criteria on effect estimation

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Weight reduction and pharmacologic treatment in obese hypertensives

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3952198

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT374

Long-term use of antihypertensive drugs and risk of cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT374

Cancer risk and mortality in users of calcium channel blockers. A cohort study

21 January 2018

1 reference

12 December 2020

Neovascularization produced by angiotensin II

1 reference

12 December 2020

Chronic calcium antagonist use in carcinoma of the lung and colon: a retrospective cohort observational study

1 reference

12 December 2020

Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJT374

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24431411

1 reference